We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,990 hedge funds and large institutions have $267B invested in Johnson & Johnson in 2019 Q4 according to their latest regulatory filings, with 373 funds opening new positions, 1,140 increasing their positions, 1,233 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

465% more first-time investments, than exits

New positions opened: 373 | Existing positions closed: 66

22% more funds holding in top 10

Funds holding in top 10: 485592 (+107)

14% more capital invested

Capital invested by funds: $233B → $267B (+$33.7B)

14% more call options, than puts

Call options by funds: $2.66B | Put options by funds: $2.33B

10% more funds holding

Funds holding: 2,7242,990 (+266)

1.21% more ownership

Funds ownership: 68.38%69.59% (+1.2%)

8% less repeat investments, than reductions

Existing positions increased: 1,140 | Existing positions reduced: 1,233

Holders
2,990
Holders Change
+266
Holders Change %
+9.77%
% of All Funds
58.92%
Holding in Top 10
592
Holding in Top 10 Change
+107
Holding in Top 10 Change %
+22.06%
% of All Funds
11.67%
New
373
Increased
1,140
Reduced
1,233
Closed
66
Calls
$2.66B
Puts
$2.33B
Net Calls
+$334M
Net Calls Change
+$537M
Name Holding Trade Value Shares
Change
Change in
Stake
CPA
1626
Cowen Prime Advisors
New York
$2.66M +$94.9K +700 +4%
SC
1627
Slow Capital
California
$2.66M +$122K +898 +5%
AA
1628
Altman Advisors
Illinois
$2.66M +$21.8K +161 +0.9%
WP
1629
WealthSource Partners
California
$2.66M +$876K +6,457 +55%
WBC
1630
West Branch Capital
Massachusetts
$2.65M +$904K +6,663 +58%
BIA
1631
BMT Investment Advisors
Pennsylvania
$2.65M
TWM
1632
Torch Wealth Management
Ohio
$2.65M -$530K -3,904 -18%
UBPAM
1633
Union Bancaire Privee Asset Management
New York
$2.65M +$366K +2,700 +17%
RIG
1634
Renaissance Investment Group
Massachusetts
$2.65M +$29.6K +218 +1%
FIM
1635
Fernwood Investment Management
Massachusetts
$2.64M -$298K -2,200 -11%
TPA
1636
Trivium Point Advisory
Connecticut
$2.64M +$65.4K +482 +3%
SIC
1637
Shoker Investment Counsel
Ohio
$2.63M -$543 -4 -0%
AFA
1638
Arlington Financial Advisors
California
$2.63M -$970K -7,153 -28%
RA
1639
RFG Advisory
Alabama
$2.63M +$146K +1,075 +6%
HWA
1640
HCR Wealth Advisors
California
$2.61M +$195K +1,441 +9%
MC
1641
Middleton & Co
Massachusetts
$2.61M -$1.27M -9,375 -34%
SNBOSCI
1642
Security National Bank of Sioux City Iowa
Iowa
$2.61M +$22.9K +169 +1%
HCMT
1643
Highland Capital Management (Tennessee)
Tennessee
$2.61M -$6.89M -50,775 -74%
MFGP
1644
Marshall Financial Group (Pennsylvania)
Pennsylvania
$2.61M -$216K -1,593 -8%
CPIA
1645
Cornell Pochily Investment Advisors
New York
$2.6M -$381K -2,806 -14%
UCMOK
1646
United Capital Management of KS
Kansas
$2.6M +$210K +1,550 +10%
FI
1647
Fosun International
China
$2.59M
CGL
1648
Clarius Group LLC
Washington
$2.59M -$4.61K -34 -0.2%
TIA
1649
Tiemann Investment Advisors
California
$2.58M -$33.1K -244 -1%
CPSC
1650
Carl P. Sherr & Co
Massachusetts
$2.58M +$2.4M +17,712 New

JNJ Hedge Fund Activity: Q4 2019 in Review

2,990 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2019, worth a combined $267B — up 14% from $233B a quarter earlier.

Buyers outnumbered sellers: 373 funds opened new JNJ positions and 66 closed out — a net gain of 307 holders — while 1,140 added to existing stakes and 1,233 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $783M. The largest seller was Capital World Investors, cutting an estimated $1.27B.

  • 2,990 institutional investors held Johnson & Johnson (JNJ) as of Q4 2019, up from 2,724 in Q3 2019.
  • Funds reported $267B of Johnson & Johnson stock for Q4 2019, up 14% quarter-over-quarter.
  • 373 funds opened new Johnson & Johnson positions in Q4 2019 and 66 closed out, a net change of +307 holders.
  • The largest Johnson & Johnson buyer in Q4 2019 was JP Morgan Chase, an estimated $783M added.
  • The largest Johnson & Johnson seller in Q4 2019 was Capital World Investors, an estimated $1.27B sold.

Based on aggregated 13F filings for Q4 2019.